Head Line News
- 11-01-2021
- Whiz Partners Established a New Company to Generate Composition of Matter Patents for New Chemical Entities and Contribute to the R&D of Pharmaceutical Companies
- 10-01-2021
- Establishment of Healthcare New Platform Fund Limited Partnership
- 06-23-2021
- Whiz Partners Announces Appointment of COO and CIO as Members of the Board
- 05-27-2021
- Axcelead Decided to Build an mRNA Drug Manufacturing Plant in Minamisoma City, Fukushima Prefecture
- 04-27-2021
- Axcelead Launches ARCALIS, a Joint Venture to Manufacture mRNA Therapeutics
- 04-23-2021
- Notice of the Execution of a Contract with the Japan Agency for Medical Research and Development
NanoCarrier and Axcelead Establish PrimRNA, a New Company Involved in the Development of mRNA Therapeutics - 04-22-2021
- Axcelead’s partner company – AXEL MARK announces the press release about business alliance with Ascella Biosystems